What is Minerva Surgical?
Headquartered in Santa Clara, California, Minerva Surgical operates as a commercial-stage medical technology enterprise. The company specializes in the development, manufacturing, and commercialization of advanced, minimally invasive medical devices designed to address critical uterine healthcare needs. By focusing on high-impact, patient-centric solutions, Minerva Surgical has carved out a distinct niche in the competitive medtech market, prioritizing clinical efficacy and procedural efficiency for healthcare providers.
The company's core competencies lie in its ability to bridge the gap between complex engineering and practical clinical application. As a leader in the uterine health space, Minerva Surgical continues to refine its product pipeline, ensuring that its technological advancements align with the evolving standards of gynecological care and the increasing demand for outpatient-friendly medical interventions.
How much funding has Minerva Surgical raised?
Minerva Surgical has raised a total of $115.9M across 10 funding rounds:
Multiple Rounds
$9M
Debt
$1.5M
Private Equity
$26.2M
Private Equity
$20M
Private Equity
$25.5M
Private Equity
$15M
Private Equity
$16.7M
Debt
$2M
Debt (2010): $1M, investors not publicly disclosed
Private Equity (2010): $6M, investors not publicly disclosed
Debt (2010): $2M supported by New Enterprise Associates
Debt (2011): $1.5M, investors not publicly disclosed
Private Equity (2011): $26.2M, investors not publicly disclosed
Private Equity (2012): $20M, investors not publicly disclosed
Private Equity (2014): $25.5M, investors not publicly disclosed
Private Equity (2015): $15M, investors not publicly disclosed
Private Equity (2016): $16.7M, investors not publicly disclosed
Debt (2020): $2M backed by PPP
Key Investors in Minerva Surgical
New Enterprise Associates
Established in 1977 and headquartered in Menlo Park, California, New Enterprise Associates is a venture capital firm focused on helping entrepreneurs build businesses.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Minerva Surgical?
Looking ahead, the infusion of capital from the recent strategic investment will likely be directed toward accelerating market penetration and expanding the reach of its existing product suite. Given the company's lifecycle stage, the focus is expected to shift toward optimizing commercial distribution channels and potentially exploring next-generation R&D initiatives to maintain its competitive edge. The strategic deployment of these funds will be pivotal in navigating the complexities of the medical device regulatory environment while scaling operations to meet global demand.
Furthermore, the company is poised to leverage its established reputation to forge deeper partnerships within the healthcare ecosystem. By prioritizing operational excellence and clinical outcomes, Minerva Surgical is set to reinforce its status as a cornerstone of modern uterine healthcare, ensuring that its technological advancements continue to provide tangible benefits to both clinicians and patients alike.
